Blog

Rahul Banerjee: MajesTEC-1 analysis of response predictors in Multiple Myeloma by Cortes-Selva

Rahul Banerjee/X

Aug 10, 2024, 12:42

Rahul Banerjee: MajesTEC-1 analysis of response predictors in Multiple Myeloma by Cortes-Selva

Rahul Banerjee, Assistant Professor at University of Washington, shared a post on X:

“EXCELLENT Blood Journal MajesTEC-1 analysis of response predictors in MMsm (Cortes-Selva et al).

Article focuses on T cells, mehh – I’ll focus on fascinating BCMA facts instead.

BCMA on BMPCs (flow) does NOT predict ORR.
Lower sBCMA is better.”

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study

Authors: Diana Cortes-Selva, Tatiana Perova, Sheri Skerget, Deeksha Vishwamitra, Sarah Stein, Rengasamy Boominathan, Onsay Lau, Karl Calara-Nielsen, Cuc Davis, Jaymala Patel, Arnob Banerjee, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Jenna Goldberg, Lixia Pei, Danielle Trancucci, Suzette Girgis, Shun Xin Wang Lin, Liviawati S Wu, Philippe Moreau, Saad Z Usmani, Nizar J Bahlis, Niels W C J van de Donk, and Raluca I Verona.

For more information.

Source: Rahul Banerjee/X

Blood Journal cancer Diana Cortes-Selva MajesTEC-1 Niels W. C. J. van de Donk Nizar J Bahlis OncoDaily Oncology Rahul Banerjee Raluca I Verona Sheri Skerget Tatiana Perova

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage